Mass vaccination, immunity and coverage: modelling population protection against foot-and-mouth disease in Turkish cattle

被引:21
作者
Knight-Jones, T. J. D. [1 ,2 ]
Gubbins, S. [1 ]
Bulut, A. N. [3 ]
Staerk, K. D. C. [2 ]
Pfeiffer, D. U. [2 ]
Sumption, K. J. [4 ]
Paton, D. J. [1 ]
机构
[1] Pirbright Inst, Pirbright, England
[2] Univ London, Royal Vet Coll VEEPH, London WC1E 7HU, England
[3] Sap Inst, Ankara, Turkey
[4] FAO, European Commiss Control FMD, I-00100 Rome, Italy
基金
英国生物技术与生命科学研究理事会;
关键词
LIQUID-PHASE; POTENCY; VIRUS; VACCINES; ELISA; ANTIBODIES; CHALLENGE;
D O I
10.1038/srep22121
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Foot-and-mouth disease (FMD) in Turkey is controlled using biannual mass vaccination of cattle. However, vaccine protection is undermined by population turnover and declining immunity. A dynamic model of the Turkish cattle population was created. Assuming biannual mass vaccination with a single-dose primary course, vaccine history was calculated for the simulated population (number of doses and time since last vaccination). This was used to estimate population immunity. Six months after the last round of vaccination almost half the cattle aged <24 months remain unvaccinated. Only 50% of all cattle would have received >1 vaccine dose in their life with the last dose given <= 6 months ago. Five months after the last round of vaccination two-thirds of cattle would have low antibody titres (<70% protection threshold). Giving a two-dose primary vaccination course reduces the proportion of 6-12 month old cattle with low titres by 20-30%. Biannual mass vaccination of cattle leaves significant immunity gaps and over-reliance on vaccine protection should be avoided. Using more effective vaccines and vaccination strategies will increase population immunity, however, the extent to which FMD can be controlled by vaccination alone without effective biosecurity remains uncertain.
引用
收藏
页数:10
相关论文
共 48 条
[1]   VARIATION AMONG STRAINS OF TYPE-A FOOT-AND-MOUTH-DISEASE VIRUS IN EASTERN MEDITERRANEAN REGION 1964-1972 [J].
ARROWSMITH, AEM .
JOURNAL OF HYGIENE, 1975, 75 (03) :387-397
[2]  
Askaroglu H., 2009, EU PROJECT CONTROL F
[3]   Foot-and-mouth disease vaccination in South Sudan: Benefit-cost analysis and livelihoods impact [J].
Barasa, M. ;
Catley, A. ;
Machuchu, D. ;
Laqua, H. ;
Puot, E. ;
Kot, D. Tap ;
Ikiror, D. .
TRANSBOUNDARY AND EMERGING DISEASES, 2008, 55 (08) :339-351
[4]   Foot-and-mouth disease vaccine potency testing: determination and statistical validation of a model using a serological approach [J].
Barnett, PV ;
Statham, RJ ;
Vosloo, W ;
Haydon, DT .
VACCINE, 2003, 21 (23) :3240-3248
[5]   High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus [J].
Brehm, K. E. ;
Kumar, N. ;
Thulke, H. -H. ;
Haas, B. .
VACCINE, 2008, 26 (13) :1681-1687
[6]  
Bulut A. N., 2014, 5 W EUR ROADM M AST
[7]  
Bulut A. N., 2013, 4 ANN REG PROGR REV
[8]  
Bulut A. N., 2015, 6 W EUR ROADM M ALM
[9]   Longevity of protection in cattle following immunisation with emergency FMD A22 serotype vaccine from the UK strategic reserve [J].
Cox, Sarah J. ;
Carr, B. Veronica ;
Parida, Satya ;
Hamblin, Pip A. ;
Prentice, Helen ;
Charleston, Bryan ;
Paton, David J. ;
Barnett, Paul V. .
VACCINE, 2010, 28 (11) :2318-2322
[10]   Prevalence of foot-and-mouth disease antibodies in dairy herds in the Netherlands four years after vaccination [J].
Dekker, A ;
Terpstra, C .
RESEARCH IN VETERINARY SCIENCE, 1996, 61 (01) :89-91